0001171843-22-005617.txt : 20220811 0001171843-22-005617.hdr.sgml : 20220811 20220811161149 ACCESSION NUMBER: 0001171843-22-005617 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220810 FILED AS OF DATE: 20220811 DATE AS OF CHANGE: 20220811 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Levitz Michael L CENTRAL INDEX KEY: 0001468019 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14027 FILM NUMBER: 221155973 MAIL ADDRESS: STREET 1: C/O ANALOGIC CORPORATION STREET 2: 8 CENTENNIAL DRIVE CITY: PEABODY STATE: MA ZIP: 01960 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anika Therapeutics, Inc. CENTRAL INDEX KEY: 0000898437 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043145961 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: (781) 457-9000 MAIL ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC DATE OF NAME CHANGE: 19970114 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA RESEARCH INC DATE OF NAME CHANGE: 19930309 4 1 ownership.xml X0306 4 2022-08-10 0 0000898437 Anika Therapeutics, Inc. ANIK 0001468019 Levitz Michael L 32 WIGGINS AVENUE BEDFORD MA 01730 0 1 0 0 EVP, CFO, Treasurer Common Stock 2022-08-10 4 M 0 3859 0 A 20423 D Restricted Stock Unit 0.00 2022-08-10 4 M 0 3859 0 D Common Stock 3859 3859 D Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on August 10, 2020. The 3,859 shares resulting from the RSU vest were retained in full as a result of Mr. Levitz's election to pay cash to cover the applicable taxes resulting from the RSU vest. Includes 640 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on May 13, 2022. Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning August 10, 2021. /s/ Michael L. Levitz 2022-08-11